|
|
 |
|
Viewing report
|
|
|
|
Personalized Medicine - Opening Doors and Overcoming Challenges
CBR Pharma Insights, Nov 2009, Pages: 51
Over the last 20 years personalized medicine has grown as tool in patient treatment. Personalized medicine uses a patient’s genetic information to help tailor treatment to avoid side effects, identify what treatments will and won’t work and establish a pre-disposition towards certain diseases.
Personalized medicine has been focused to a great degree in the oncology area, where on average an individual patient may find more than 70% of medicines ineffective for them. In the last few years this has begun to change as more personalized medicines have been developed outside of the oncology field. The spread of personalized medicine to other fields has increased the challenge of physician uptake, with many GPs not feeling comfortable ordering genetic tests.
Personalized medicine faces a number of road blocks, including the issues of physician uptake of diagnostics, challenges for clinical trials, public controversy and, most significantly, lack of reimbursement by payers.
“Personalized Medicine – Opening Doors and Overcoming Challenges” provides insights & analysis on this important issue and the strategies pharmaceutical companies can employ to support the future growth of their business.
Reasons to Purchase
- Gain access to a fully sourced, executive assessment of the “in’s and out’s” of personalized medicine
- Benefit from CBR’s evaluation of the key areas where personalized medicine is used through our case study analysis
- Identify opportunities where your company can strengthen its portfolio through the use of personalized medicine
- Understand the recent US legislature which will have the greatest impact on the growth of personalized medicine
- Identify the road blocks to the growth of personalized medicine and what can be done to overcome them
|
|
|
|
